How to buy Celularity stock | $10.13

Celularity Inc is a shell companies business based in the US. Celularity shares (GXGX) are listed on the NASDAQ and all prices are listed in US Dollars.

Celularity stock price (NASDAQ: GXGX)

Use our graph to track the performance of GXGX stocks over time.

Celularity shares at a glance

• Key figures

Information last updated 2021-09-12.

Latest market close	$10.13
52-week range	$8.07 - $12.17
50-day moving average	$10.06
200-day moving average	$10.14
Wall St. target price	N/A
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	$-0.49

Buy Celularity shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy Celularity stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Celularity price performance over time

Historical closes compared with the close of $10.13 from 2021-05-28

1 week (2021-10-05)	N/A
1 month (2021-09-12)	N/A
3 months (2021-07-16)	-0.69%
6 months (2021-04-15)	0.30%

1 year (2020-10-15)	-4.07%
2 years (2019-10-15)	2.01%
3 years (2018-10-12)	N/A
5 years (2016-10-12)	N/A

Celularity financials

Gross profit TTM	$0
Return on assets TTM	-1.29%
Return on equity TTM	-52.61%
Profit margin	0%
Book value	$0.67
Market capitalisation	$201.6 million

TTM: trailing 12 months

Shorting Celularity shares

There are currently 760,441 Celularity shares held short by investors – that's known as Celularity's "short interest". This figure is 22.7% up from 619,740 last month.

There are a few different ways that this level of interest in shorting Celularity shares can be evaluated.

Celularity's "short interest ratio" (SIR)

Celularity's "short interest ratio" (SIR) is the quantity of Celularity shares currently shorted divided by the average quantity of Celularity shares traded daily (recently around 108945.70200573). Celularity's SIR currently stands at 6.98. In other words for every 100,000 Celularity shares traded daily on the market, roughly 6980 shares are currently held short.

However Celularity's short interest can also be evaluated against the total number of Celularity shares, or, against the total number of tradable Celularity shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Celularity's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 Celularity shares in existence, roughly 40 shares are currently held short) or 0.0307% of the tradable shares (for every 100,000 tradable Celularity shares, roughly 31 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Celularity.

Find out more about how you can short Celularity stock.

Celularity share dividends

We're not expecting Celularity to pay a dividend over the next 12 months.

Celularity overview

Celularity Inc. , a biopharmaceutical company, develops placental-derived off-the-shelf therapeutic and cellular medicines for cancer, infectious diseases, and degenerative diseases. The company offers Biovance, a human amniotic membrane allograft that provides a protective cover and supports the body's wound healing processes; and Interfyl, a connective tissue matrix for various surgical applications when there is a need to replace and supplement damaged or inadequate integumental tissue. It also offers allogeneic placenta-derived cell therapy product candidates. The company was incorporated in 2016 and is based in Florham Park, New Jersey. .

Frequently asked questions

What percentage of Celularity is owned by institutions?
Currently 83.535% of Celularity shares are held by institutions. When does the fiscal year end for Celularity?
Celularity's fiscal year ends in December. Where is Celularity based?
Celularity's address is: 170 Park Ave, Florham Park, NJ, United States, 07932 What is Celularity's ISIN number?
Celularity's international securities identification number is: US1511901050